You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bispecific

Showing 551 - 569 of 569
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumors Trial in Indianapolis, Boston, Salt Lake City (MM-111 + Herceptin)

Completed
Has Results
  • Breast Neoplasms
  • MM-111 + Herceptin
  • Indianapolis, Indiana
  • +2 more
Dec 18, 2014

Gastric Cancer, Gastric Adenocarcinoma Trial in Worldwide (Catumaxomab, catumaxomab)

Completed
  • Gastric Cancer
  • Gastric Adenocarcinoma
  • Innsbruck, Austria
  • +3 more
Dec 3, 2013

Multiple Myeloma and Plasma Cell Tumor Trial in Detroit (anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells,

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells
  • +2 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Sep 20, 2013

Malignant Melanoma Trial in Tuebingen (rM28, autologous PBMCs)

Completed
  • Malignant Melanoma
  • Tuebingen, Germany
    University of Tuebingen, Department of dermatology
Jan 15, 2013

Colorectal Tumors Trial in Nijmegen (TF2, IMP-288 labeled with In111 and Lu177)

Completed
  • Colorectal Neoplasms
  • TF2
  • IMP-288 labeled with In111 and Lu177
  • Nijmegen, Netherlands
    Radboud University Nijmegen Medical Centre
Mar 16, 2012

Malignant Ascites Due to Epithelial Carcinoma Trial in Berlin (catumaxomab)

Completed
  • Malignant Ascites Due to Epithelial Carcinoma
  • Berlin, Germany
    Charité Campus Virchow Clinic
Oct 2, 2012

Ovarian Cancer, Epithelial Ovarian Cancer Trial in Innsbruck, Berlin (Catumaxomab)

Completed
  • Ovarian Cancer
  • Epithelial Ovarian Cancer
  • Innsbruck, Austria
  • +1 more
Oct 2, 2012

Brain and CNS Tumors Trial in Lebanon (bispecific antibody MDX447, lymphokine-activated killer cells, conventional surgery)

Completed
  • Brain and Central Nervous System Tumors
  • bispecific antibody MDX447
  • +2 more
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Oct 26, 2011

Cancer, Tumors, Carcinoma Trial in Several (Catumaxomab, Prednisolone)

Completed
  • Cancer
  • +3 more
  • Several, France
  • +3 more
Oct 2, 2012

Thyroid Tumors Trial in France (bispecific antibody and di-DTPA-131I)

Completed
  • Thyroid Neoplasms
  • bispecific antibody and di-DTPA-131I
  • Caen, France
  • +10 more
Nov 10, 2011

Ovarian Cancer Trial in United States (catumaxomab)

Completed
Has Results
  • Ovarian Cancer
  • Tucson, Arizona
  • +11 more
Jul 16, 2012

Metastatic Solid Tumors Trial in Jerusalem (Cell therapy with bispecific antibodies)

Withdrawn
  • Metastatic Solid Tumors
  • Cell therapy with bispecific antibodies
  • Jerusalem, Israel
    Hadassah Medical Organization
Apr 7, 2011

Metastatic Breast Cancer, Advanced Breast Cancer Trial in Canada, United States (ertumaxomab)

Terminated
Has Results
  • Metastatic Breast Cancer
  • Advanced Breast Cancer
  • Minneapolis, Minnesota
  • +4 more
Apr 28, 2011

Metastatic Breast Cancer, Advanced Breast Cancer Trial in Study site, Study sites, Barcelona (ertumaxomab)

Terminated
  • Metastatic Breast Cancer
  • Advanced Breast Cancer
  • ertumaxomab
  • Study site, Austria
  • +4 more
May 18, 2009

EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast), Malignant Ascites Trial (Catumaxomab (Removab), paracentesis)

Completed
  • EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast)
  • Malignant Ascites
  • Catumaxomab (Removab)
  • paracentesis
  • (no location specified)
Feb 4, 2009

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin Trial (MEDI-538)

Withdrawn
  • Lymphoma, B-Cell
  • Lymphoma, Non-Hodgkin
  • (no location specified)
Sep 4, 2008

Chronic Lymphocytic Leukemia Trial (MEDI-538)

Withdrawn
  • Chronic Lymphocytic Leukemia
  • (no location specified)
Sep 4, 2008

Gastric Cancer, Gastric Adenocarcinoma Trial in Cologne (catumaxomab)

Completed
  • Gastric Cancer
  • Gastric Adenocarcinoma
  • Cologne, Germany
    Hospital of Cologne-Merheim, Surgical Department
Oct 25, 2007

Ovarian Cancer, Fallopian Tube Tumors, Peritoneal Tumors Trial in Marburg (anti-EpCAM x anti-CD3 (removab))

Completed
  • Ovarian Cancer
  • +2 more
  • anti-EpCAM x anti-CD3 (removab)
  • Marburg, Germany
    Dept. of Gynecology, University of Marburg
Nov 7, 2006